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       Lysosomes are important organelles for cellular homeostasis with their involvements in 
degradation of biomolecules, cell signaling and energy metabolism, which are related to health and 
diseases. The function of lysosomes depend on coordinated action of lysosomal hydrolyzes and 
lysosomal membrane-bound proteins. Mutations on the coding region of these proteins cause defective 
lysosomal functions and accumulation of un-metabolized substrates, which contributes to the 
pathogenesis of lysosomal storage diseases. Substrates are transported to lysosomes through different 
mechanism such as endocytosis, phagocytosis or autophagy. Autophagy is a conserved cellular 
pathway, that lead to the engulfment of portions of the cytoplasm and organelles and then delivers the 
cargo to lysosomes for degradation. Autophagic degradation is relies on the ability of lysosomal 
membrane fusion with autophagic vesicle membrane, therefore disorders in lysosomal action may 
directly effect on autophagy. Gaucher disease is a lysosomal storage disease resulting from the 
mutation of a lysosomal membrane-associated glycoprotein glucocerebrosidase (GBA) and GBA 
cofactor of sapozin C. The disease leads to the intracellular accumulation of glucosylceramide and 
other glycolipids.  In order to show, the effect of autophagy abnormalities to the Gaucher disease, we 
analyzed the expression of autophagy and/or lysosome-related genes and proteins in fibroblast cells 
isolated from patients with different mutations. We observed significant attenuation in 
autophagy/lysosome-related gene in patient fibroblast cells. We also observed a mutation-type 
dependent accumulation of some autophagy proteins. Moreover, there was a clear lysosome and 
lysosomal protein accumulation and an increase in lysosome numbers in starved-patient cells. 
Biochemical and morphological analyses of autophagy revealed some abnormalities in mutant cells, 
suggesting that autophagy is directly affected in Gaucher patient cells. (This project is supported by 
TUBITAK-3501-National Young Researchers Carreer Development Program, Project No: 
112T130)  
  
 
